New cancer clinical trial: Accelerated Hypofractionated or Conventionally Fractionated Radiotherapy and Durvalumab in Treating Patients With Stage II-III Non-small Cell Lung Cancer

Published on: January 14, 2019 at 10:30PM

• Tweet
• Share
• Share
• Share
• Share